Ma YD - Search Results

1

[Effects of AMPK on the transcriptional activity of FOXO1 and ubiquitin ligase MuRF1 expression in rat cardiomyocytes].

Chen BL, Xiong ZJ, Zhang CX, Ma YD, Meng RS, Chen GQ, Liu C, Dong YG. Chen BL, et al. Among authors: ma yd. Nan Fang Yi Ke Da Xue Xue Bao. 2010 Nov;30(11):2419-22. Nan Fang Yi Ke Da Xue Xue Bao. 2010. PMID: 21097394 Chinese.

2

Adenosine monophosphate-activated protein kinase attenuates cardiomyocyte hypertrophy through regulation of FOXO3a/MAFbx signaling pathway.

Chen B, Wu Q, Xiong Z, Ma Y, Yu S, Chen D, Huang S, Dong Y. Chen B, et al. Acta Biochim Biophys Sin (Shanghai). 2016 Sep;48(9):827-32. doi: 10.1093/abbs/gmw076. Epub 2016 Aug 12. Acta Biochim Biophys Sin (Shanghai). 2016. PMID: 27521792 Free article.

3

Activation of AMPK inhibits cardiomyocyte hypertrophy by modulating of the FOXO1/MuRF1 signaling pathway in vitro.

Chen BL, Ma YD, Meng RS, Xiong ZJ, Wang HN, Zeng JY, Liu C, Dong YG. Chen BL, et al. Among authors: ma yd. Acta Pharmacol Sin. 2010 Jul;31(7):798-804. doi: 10.1038/aps.2010.73. Epub 2010 Jun 28. Acta Pharmacol Sin. 2010. PMID: 20581852 Free PMC article.

4

Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats.

Zhang CX, Pan SN, Meng RS, Peng CQ, Xiong ZJ, Chen BL, Chen GQ, Yao FJ, Chen YL, Ma YD, Dong YG. Zhang CX, et al. Among authors: ma yd. Clin Exp Pharmacol Physiol. 2011 Jan;38(1):55-62. doi: 10.1111/j.1440-1681.2010.05461.x. Clin Exp Pharmacol Physiol. 2011. PMID: 21083698

5

MG132, a proteasome inhibitor, attenuates pressure-overload-induced cardiac hypertrophy in rats by modulation of mitogen-activated protein kinase signals.

Chen B, Ma Y, Meng R, Xiong Z, Zhang C, Chen G, Zhang A, Dong Y. Chen B, et al. Acta Biochim Biophys Sin (Shanghai). 2010 Apr;42(4):253-8. doi: 10.1093/abbs/gmq012. Acta Biochim Biophys Sin (Shanghai). 2010. PMID: 20383463 Free article.

6

Artemisinin, an anti-malarial agent, inhibits rat cardiac hypertrophy via inhibition of NF-κB signaling.

Xiong Z, Sun G, Zhu C, Cheng B, Zhang C, Ma Y, Dong Y. Xiong Z, et al. Eur J Pharmacol. 2010 Dec 15;649(1-3):277-84. doi: 10.1016/j.ejphar.2010.09.018. Epub 2010 Sep 19. Eur J Pharmacol. 2010. PMID: 20863781

7

MG132 treatment attenuates cardiac remodeling and dysfunction following aortic banding in rats via the NF-κB/TGFβ1 pathway.

Ma Y, Chen B, Liu D, Yang Y, Xiong Z, Zeng J, Dong Y. Ma Y, et al. Biochem Pharmacol. 2011 May 15;81(10):1228-36. doi: 10.1016/j.bcp.2011.03.009. Epub 2011 Mar 21. Biochem Pharmacol. 2011. PMID: 21420391

8

Proteasome inhibition attenuates heart failure during the late stages of pressure overload through alterations in collagen expression.

Ma Y, Chen Y, Yang Y, Chen B, Liu D, Xiong Z, Zhang C, Dong Y. Ma Y, et al. Biochem Pharmacol. 2013 Jan 15;85(2):223-33. doi: 10.1016/j.bcp.2012.10.025. Epub 2012 Nov 8. Biochem Pharmacol. 2013. PMID: 23142711

9

Effects of Long-Term Statin Therapy in Coronary Artery Disease Patients with or without Chronic Kidney Disease.

Huang H, Zeng C, Ma Y, Chen Y, Chen C, Liu C, Dong Y. Huang H, et al. Dis Markers. 2015;2015:252564. doi: 10.1155/2015/252564. Epub 2015 Oct 8. Dis Markers. 2015. PMID: 26557729 Free PMC article.

10

AMPK attenuates ventricular remodeling and dysfunction following aortic banding in mice via the Sirt3/Oxidative stress pathway.

Chen Y, Chen C, Dong B, Xing F, Huang H, Yao F, Ma Y, He J, Dong Y. Chen Y, et al. Eur J Pharmacol. 2017 Nov 5;814:335-342. doi: 10.1016/j.ejphar.2017.08.042. Epub 2017 Sep 1. Eur J Pharmacol. 2017. PMID: 28867609

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters